Ethicon Physiomesh Lawsuits
Lawsuits are being filed against the Johnson & Johnson subsidiary Ethicon alleging its Physiomesh Flexible Composite Mesh is a defective product. The abdominal mesh, which is used in laparoscopic hernia surgeries, has been linked to higher than normal revision rates than other surgical hernia mesh products. Ethicon announced a Physiomesh Flexible Composite Mesh withdrawal after patients suffered numerous adverse hernia side effects, including hernia mesh revision surgery. Physiomesh lawyers are investigating Ethicon complaints nationwide, and an Ethicon Physiomesh class action lawsuit has been filed in Canada.
FREE ETHICON PHYSIOMESH LAWSUIT EVALUATION
GET LEGAL HELP NOW
Ethicon Physiomesh Flexible Composite Mesh
- recurrence of the hernia;
- bacterial infection—marked by fever and chills;
- pain or swelling at the operative site;
- , fluid-filled abscesses in the abdomen and groin;
- perforation of the organs or blood vessels.
Ethicon Physiomesh Recall
The two studies involved unpublished data from a pair of European registries that found a discrepancy between Physiomesh flexible composite and the other meshes in the registries after laparoscopic ventral hernia repair. In a letter to healthcare providers, the West Somerville, N.J.-based Ethicon believes higher revision rates are due to a “multifactorial issue,” possibly including “product characteristics, operative and patient factors,” but hasn’t been able to pin down a cause.
Ethicon said that patients already implanted with the product should be followed as usual. The recall does not involve any other Ethicon meshes, including the Physiomesh Open flexible composite mesh.
(In June 2012, Ethicon removed four transvaginal meshes from the market- Prolift, ProliftM+, TVT Secur and Prosima Pelvic Floor Repair System, stating the products were removed for business reasons.)
Ethicon Physiomesh and the FDA
Ethicon Physiomesh was approved by the FDA in March 2010. Here is the submission and approval , which doesn’t require human clinical trials and does not require a premarket approval application (PMA), as longs as it can be demonstrated that the new product is substantially equivalent to another device that was previously approved by the FDA. (The FDA’s 510(k) has a reputation for being easy, inexpensive, and less thorough.)
Ethicon told the FDA that its Flexible Composite Mesh met all testing criteria, demonstrated substantial equivalence to its predicate devices and did not raise any new questions of safety or effectiveness.
An Ethicon Physiomesh study showed that the mesh has a much higher failure rate than other widely available hernia mesh products: 20 percent of Ethicon Physiomesh implants fail within six months of implantation, requiring patients to undergo hernia revision surgery. Further, with each surgery, scar tissue build-up makes every revision attempt less likely to succeed. This hernia mesh is more likely to cause adhesions, seromas, hemorrhage and lower tissue integration in patients.
Ethicon Physiomesh Lawsuits
The first physiomesh lawsuit was filed by Matthew Huff, just weeks before the mesh was withdrawn by the company, alleging that the hernia repair mesh was defective, unreasonably dangerous and not suitable for use. Huff developed severe abdominal pain, ever, chills, nausea and redness. He was treated for an infection and two abscesses and an intestinal fistula. The trial is set for January 2018 in the Southern District of Illinois. (Case No. 3:16-cv-00368-JPG-PMF)
A Florida woman in September 2016 filed a lawsuit following failed incisional hernia repair in May 2014 with Ethicon’s Physiomesh Flexible Composite Mesh (Product Code PHY2025V). After hernia surgery, Joanne Quinn experienced persistent abdominal pain, diminished bowel motility and bowel obstruction. She underwent a revision surgery in July 2015 but the surgeon was unable to remove all of the allegedly defective material from her body. In the lawsuit, Quinn claims that she will likely suffer pain and medical complications for the rest of her life due to debris from the hernia patch that remains in her abdominal wall. She further claims that Physiomesh is made from materials that are not inert and that react to human tissues, placing patients at risk for chronic pain, infection, hernia recurrence, adhesions, intestinal blockage, mesh migration, mesh contraction and repeated surgery.
Legal HelpIf you or a loved one has suffered similar damages or injuries, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Last updated on
Abdominal Mesh Victim Prescribed Oxycontin--Could the Pain have been Avoided if Medical Devices were Tested?
Ethicon Physiomesh Bellwether Trials to Start in September, 2019
READ MORE Defective Products Settlements and Legal News
READ MORE Drugs/Medical Settlements and Legal News
READ MORE Personal Injury Settlements and Legal News